SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego biotech MEI Pharma signed a major deal with Swiss pharmaceutical group Helsinn that could be worth up to $464 million.
San Diego’s Orexigen Therapeutics Inc. reported a jump in quarterly revenue, but missed Wall Street’s expectations for total earnings-per-share, according to a recent earnings statement.
AMN Healthcare Inc. reported a 35 percent increase in revenue compared with the like quarter of the previous year in its second-quarter earnings report released Aug. 4.
Biotech veteran David Hale, who has been involved in San Diego’s life science industry for decades, has launched a new company, Adigica Health, Inc., to develop and commercialize specialty healthcare and skincare products directly to consumers.
MEDICINE: Blue Shield Rate Increase to Average 20%
Scripps Health’s reputation for inspiring loyalty among patients may soon be put to the test as its sole partner in the state-run insurance exchange, Blue Shield of California, plans a rate increase dwarfing those of its closest rivals in the highly competitive San Diego market.
La Jolla-based Ambrx Inc. has raised $45 million in new cash.
Carlsbad drugmaker Ionis Pharmaceuticals Inc. has received $75 million from its partner Biogen following news of positive Phase 3 data for its spinal muscular atrophy drug called Nusinersen.
AMN Healthcare announced it has appointed a former senior executive at McKesson Corp., Matt Zubiller, to lead strategic planning across all divisions of the San Diego-based workforce solutions and staffing services company.
Medical imaging software developer StatRad said Tuesday it has received a $13 million equity investment from an undisclosed institutional partner active in health care information technology.
San Diego biotech Evofem Inc. has raised $25 million in a Series D round.
Organovo Holdings Inc., the San Diego firm that “bioprints” three-dimensional human tissue, has appointed Craig Kussman as chief financial officer.
San Diego drugmaker Sorrento Therapeutics is launching a joint venture with South Korea’s CHA Biotech to develop an anti-cancer therapy. This is the latest in a string of joint ventures Sorrento has created in the last few months.
San Diego medical device maker DJO Global reported a bump to its net sales in the second quarter.
BIOTECH: LabCorp Buys Struggling Diagnostic Co.
San Diego’s Sequenom Inc., which has seen a string of losses in recent years, is being acquired by LabCorp, a giant in the diagnostics and lab testing industry, in a deal worth $371 million.
BIOTECH: ResMed’s Efforts In Informatics Pay Off As Company’s Value Climbs
ResMed Inc. is shoring up its position in the “internet of medical things,” funneling massive resources into its digital health portfolio and watching its stock climb as a result.